Celexa

Premature Ejaculation, Bulimia Nervosa, Panic Disorder + 7 more

Treatment

1 FDA approval

20 Active Studies for Celexa

What is Celexa

Citalopram

The Generic name of this drug

Treatment Summary

Citalopram is a type of antidepressant called a selective serotonin-reuptake inhibitor (SSRI). It is used to treat the symptoms of depression and is available in tablet and liquid form. This drug was approved by the FDA in 1998 and is commonly known by the name Celexa.

Celexa

is the brand name

image of different drug pills on a surface

Celexa Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Celexa

Citalopram

1998

424

Approved as Treatment by the FDA

Citalopram, also known as Celexa, is approved by the FDA for 1 uses like Depression .

Depression

Helps manage Depression

Effectiveness

How Celexa Affects Patients

Citalopram is an antidepressant that belongs to a group of medications known as selective serotonin reuptake inhibitors (SSRIs). It can help treat symptoms of depression, anxiety, eating disorders, and obsessive-compulsive disorder. It works by blocking the reabsorption of serotonin in the brain, which helps regulate mood, perception, reward, anger, aggression, appetite, memory, sexuality, and attention. Citalopram usually begins to take effect in 1-4 weeks, with full effects usually taking 8-12 weeks. In addition, citalopram does not inhibit the enzyme monoamine oxidase.

How Celexa works in the body

Citalopram works by blocking the nerve cells in the brain from absorbing serotonin. It specifically targets serotonin transporter proteins, which are responsible for re-absorbing serotonin from the nerves. Citalopram does not have a strong effect on other types of receptors, so it has fewer side effects than other similar drugs. It does not affect dopamine, adrenaline, histamine, or GABA receptors, which are responsible for many of the negative side effects of other medications.

When to interrupt dosage

The proposed measure of Celexa is contingent upon the observed condition, including Obsessive-Compulsive Disorder, Premenstrual Dysphoric Disorder and Diabetic Neuropathy. The amount additionally fluctuates based on the mode of delivery (e.g. Tablet - Oral or Tablet) featured in the table beneath.

Condition

Dosage

Administration

Obsessive-Compulsive Disorder

, 20.0 mg, 40.0 mg, 10.0 mg, 10.0 mg/mL, 0.4 mg, 30.0 mg, 2.0 mg/mL

, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Solution, Solution - Oral, Kit, Capsule, Capsule - Oral

Social Anxiety Disorder

, 20.0 mg, 40.0 mg, 10.0 mg, 10.0 mg/mL, 0.4 mg, 30.0 mg, 2.0 mg/mL

, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Solution, Solution - Oral, Kit, Capsule, Capsule - Oral

Generalized Anxiety Disorder

, 20.0 mg, 40.0 mg, 10.0 mg, 10.0 mg/mL, 0.4 mg, 30.0 mg, 2.0 mg/mL

, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Solution, Solution - Oral, Kit, Capsule, Capsule - Oral

Diabetic Neuropathy

, 20.0 mg, 40.0 mg, 10.0 mg, 10.0 mg/mL, 0.4 mg, 30.0 mg, 2.0 mg/mL

, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Solution, Solution - Oral, Kit, Capsule, Capsule - Oral

Anorexia Nervosa

, 20.0 mg, 40.0 mg, 10.0 mg, 10.0 mg/mL, 0.4 mg, 30.0 mg, 2.0 mg/mL

, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Solution, Solution - Oral, Kit, Capsule, Capsule - Oral

Premature Ejaculation

, 20.0 mg, 40.0 mg, 10.0 mg, 10.0 mg/mL, 0.4 mg, 30.0 mg, 2.0 mg/mL

, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Solution, Solution - Oral, Kit, Capsule, Capsule - Oral

Post Traumatic Stress Disorder

, 20.0 mg, 40.0 mg, 10.0 mg, 10.0 mg/mL, 0.4 mg, 30.0 mg, 2.0 mg/mL

, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Solution, Solution - Oral, Kit, Capsule, Capsule - Oral

Bulimia Nervosa

, 20.0 mg, 40.0 mg, 10.0 mg, 10.0 mg/mL, 0.4 mg, 30.0 mg, 2.0 mg/mL

, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Solution, Solution - Oral, Kit, Capsule, Capsule - Oral

Depression

, 20.0 mg, 40.0 mg, 10.0 mg, 10.0 mg/mL, 0.4 mg, 30.0 mg, 2.0 mg/mL

, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Solution, Solution - Oral, Kit, Capsule, Capsule - Oral

Panic Disorder

, 20.0 mg, 40.0 mg, 10.0 mg, 10.0 mg/mL, 0.4 mg, 30.0 mg, 2.0 mg/mL

, Oral, Tablet, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Solution, Solution - Oral, Kit, Capsule, Capsule - Oral

Warnings

Celexa Contraindications

Condition

Risk Level

Notes

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Citalopram may interact with Pulse Frequency

There are 20 known major drug interactions with Celexa.

Common Celexa Drug Interactions

Drug Name

Risk Level

Description

Abemaciclib

Major

The metabolism of Abemaciclib can be decreased when combined with Citalopram.

Acalabrutinib

Major

The metabolism of Acalabrutinib can be decreased when combined with Citalopram.

Alectinib

Major

The metabolism of Alectinib can be decreased when combined with Citalopram.

Aminophylline

Major

The metabolism of Aminophylline can be decreased when combined with Citalopram.

Amoxapine

Major

The metabolism of Amoxapine can be decreased when combined with Citalopram.

Celexa Toxicity & Overdose Risk

The lethal dose of citalopram in humans is 56mg/kg and 179mg/kg in mice. Symptoms of an overdose can include dizziness, sweating, nausea, vomiting, trembling, drowsiness, fast heart rate, and confusion. In rare cases, amnesia, coma, seizures, shortness of breath, muscle breakdown, and abnormal heart rhythms may occur. If an overdose occurs, supportive care should be provided and activated charcoal and vomiting may be used. This drug is considered to be of a pregnancy category C and should only be used if the potential benefits outweigh the possible risks to the fetus. Citalopram

image of a doctor in a lab doing drug, clinical research

Celexa Novel Uses: Which Conditions Have a Clinical Trial Featuring Celexa?

954 clinical trials are currently being conducted to evaluate the potential of Celexa in treating Panic Disorder, Obsessive-Compulsive Disorder and Depression.

Condition

Clinical Trials

Trial Phases

Obsessive-Compulsive Disorder

66 Actively Recruiting

Not Applicable, Phase 2, Phase 3, Phase 1, Early Phase 1

Post Traumatic Stress Disorder

239 Actively Recruiting

Not Applicable, Early Phase 1, Phase 3, Phase 4, Phase 2, Phase 1

Panic Disorder

13 Actively Recruiting

Not Applicable

Bulimia Nervosa

0 Actively Recruiting

Depression

305 Actively Recruiting

Not Applicable, Phase 1, Phase 2, Early Phase 1, Phase 4, Phase 3

Premature Ejaculation

0 Actively Recruiting

Diabetic Neuropathy

5 Actively Recruiting

Not Applicable, Phase 1, Phase 2

Social Anxiety Disorder

15 Actively Recruiting

Not Applicable

Anorexia Nervosa

0 Actively Recruiting

Generalized Anxiety Disorder

7 Actively Recruiting

Not Applicable, Phase 2, Phase 3

Celexa Reviews: What are patients saying about Celexa?

5

Patient Review

4/25/2021

Celexa for Repeated Episodes of Anxiety

Celexa has been a total game-changer for me. I was having anxiety attacks that I couldn't control, but after starting this medication, they stopped completely. Not to mention my heart palpitations calmed down and my mood improved. Would definitely recommend!

5

Patient Review

10/18/2021

Celexa for Depression

This medication has helped me a lot with my memory. I was having trouble remembering simple words or using the wrong ones, but that's no longer an issue.

5

Patient Review

2/28/2022

Celexa for Posttraumatic Stress Syndrome

Celexa has really helped me with my depression. I didn't notice a difference until after the first month, but by the third month I could really tell that things had changed for the better. If you're struggling with depression, I would recommend giving this medication a try.

5

Patient Review

3/10/2022

Celexa for Depression

I've been taking Celexa for nearly two decades and it has vastly improved the quality of my life. I only wish I had started sooner!

4.3

Patient Review

5/13/2022

Celexa for Depression

I found this medication to be really helpful at first, but then it just stopped working for me. In fact, it made me feel worse so I had to stop taking it.

3.7

Patient Review

4/15/2022

Celexa for Anxiousness associated with Depression

I didn't experience the results I was hoping for.

3.7

Patient Review

5/24/2022

Celexa for Anxiousness associated with Depression

I found that this medication helped to improve my mood and patience. It's also been effective in managing my anxiety and depression. The only downside is that I experienced some mild gastrointestinal side effects when I first started taking it.

2.7

Patient Review

12/16/2019

Celexa for Depression

I was switched to Celexa after Cipralex stopped working for me. Unfortunately, Celexa has made me sweat and I can't get a full night's sleep.

2.3

Patient Review

1/7/2020

Celexa for Depression

I felt like the depression was at bay, but it made my anxiety skyrocket. The side effects were extreme—either not enough sleep or I’d sleep the entire day, always felt unwell and nauseous, horrible headaches. I’m currently on week three of coming off of 20mg, and I keep forgetting simple words or use the wrong ones (completely out of my character)..!

2.3

Patient Review

10/15/2020

Celexa for Bipolar Depression

I had really bad side effects from Celexa, to the point where I started harming myself. Never again will I take this medication.

1

Patient Review

9/20/2020

Celexa for Depression

I started taking Celexa 10 mg. for depression two weeks ago and have since then only experienced negative side effects such as terrible headaches and nausea.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about celexa

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Celexa better than Zoloft?

"A study was done comparing the effects of two drugs for treating depression. The study found that both drugs were effective and tolerated well. However, Celexa showed earlier signs of symptom improvement than Zoloft."

Answered by AI

Is Celexa similar to Xanax?

"Celexa (citalopram) and Xanax are not the same medication. They might have some of the same side effects, but they belong to different medication classes. Celexa is a selective serotonin reuptake inhibitor (SSRI), while Xanax is a benzodiazepine."

Answered by AI

Is Celexa better for anxiety or depression?

"Celexa is a selective serotonin reuptake inhibitor (SSRI) and Xanax is a benzodiazepine.

Celexa and Xanax are two different drugs that are used to treat anxiety. Celexa is an SSRI that is primarily used to treat depression, but it can also be used to treat anxiety. Xanax is a benzodiazepine that is also used to treat panic attacks."

Answered by AI

What does Celexa do to you?

"Celexa is a medication that helps to elevate serotonin levels in the brain. Serotonin is a hormone that can impact sleep, metabolism, and mood. Low serotonin levels have been linked by research to both depression and anxiety. Celexa is typically taken once a day, either in the morning or evening, and can be taken with or without food."

Answered by AI

Clinical Trials for Celexa

Image of Columbia University Irving Medical Center in New York, United States.

Mindfulness-Based Exposure Therapy for PTSD After Cardiac Arrest

18 - 81
All Sexes
New York, NY

The goal of this clinical trial is to learn if a new therapy called Acceptance- and Mindfulness-Based Exposure Therapy (AMBET) helps treat post-traumatic stress disorder (PTSD) in people who survived a cardiac arrest. This study will compare AMBET to another psychotherapy treatment called Present Centered Therapy (PCT) to see which therapy is more effective in treating PTSD. The main questions it aims to answer are: Does AMBET reduce PTSD symptoms in survivors of cardiac arrest? How do the benefits of AMBET compare to PCT? Participants will: * Be randomly assigned to receive either AMBET or PCT * Attend 12 hours of individual psychotherapy sessions over about 12 weeks * Complete short weekly surveys about their mood and behaviors online * Wear a Fitbit device to track sleep and activity during the study * Do brief homework assignments between sessions

Waitlist Available
Has No Placebo

Columbia University Irving Medical Center

Yuval Neria, PhD

Image of The University of Texas Health Science Center at Houston in Houston, United States.

Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder

7 - 14
All Sexes
Houston, TX

One of the most common and widely disseminated trauma treatments is Trauma Focused Cognitive Behavioral Therapy (TF-CBT). TF-CBT is a therapist-led, structured and sequential intervention, with treatment organized around P.R.A.C.T.I.C.E. (Psychoeducation, Parent training, Relaxation, Affective Regulation, Cognitive Coping, Trauma Narrative, In-Vivo Exposure, Cognitive Reprocessing, and Enhancing Safety) components. Stepped Care Cognitive Behavioral Therapy for Children after Trauma (SC-CBT-CT) is an alternative delivery system that incorporates the best available evidence on the treatment of childhood Post-traumatic Stress Disorder (PTSD) within a stepped care model and utilizes task-shifting with caregiver involvement, which engages caregivers in actively helping their children. Stepped care approaches are characterized by a personalized approach to care in which a lower intensity (i.e., fewer number of sessions) intervention is initially provided before the child is reevaluated or ''stepped up'' for additional care should symptoms persist. The goal of this study is to assess a personalized modification of SC-CBT-CT for Latino families (pSC-CBT-CT). The hypothesis is that personalizing SC-CBT-CT will improve outcomes for Latino children.

Waitlist Available
Has No Placebo

The University of Texas Health Science Center at Houston

Leslie K Taylor, PhD

Image of The University of Texas Health Science Center at Houston in Houston, United States.

Personalized Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder

7 - 14
All Sexes
Houston, TX

One of the most common and widely disseminated trauma treatments is Trauma Focused Cognitive Behavioral Therapy (TF-CBT). TF-CBT is a therapist-led, structured and sequential intervention, with treatment organized around P.R.A.C.T.I.C.E. (Psychoeducation, Parent training, Relaxation, Affective Regulation, Cognitive Coping, Trauma Narrative, In-Vivo Exposure, Cognitive Reprocessing, and Enhancing Safety) components. Stepped Care Cognitive Behavioral Therapy for Children after Trauma (SC-CBT-CT) is an alternative delivery system that incorporates the best available evidence on the treatment of childhood Post-traumatic Stress Disorder (PTSD) within a stepped care model and utilizes task-shifting with caregiver involvement, which engages caregivers in actively helping their children. Stepped care approaches are characterized by a personalized approach to care in which a lower intensity (i.e., fewer number of sessions) intervention is initially provided before the child is reevaluated or ''stepped up'' for additional care should symptoms persist. The goal of this study is to assess a personalized modification of SC-CBT-CT for Latino families (pSC-CBT-CT). The hypothesis is that personalizing SC-CBT-CT will improve outcomes for Latino children.

Waitlist Available
Has No Placebo

The University of Texas Health Science Center at Houston

Leslie K Taylor, PhD

Image of University of Michigan in Ann Arbor, United States.

Virtual Reality for Depression in Multiple Sclerosis

18+
All Sexes
Ann Arbor, MI

This trial explores the use of immersive virtual reality (VR) nature-based experiences as a supplementary treatment for depression in individuals with progressive multiple sclerosis (MS). This study will evaluate the feasibility and efficacy of at-home VR deployment using the Apple Vision Pro, an advanced device that offers enhanced resolution, immersion, and usability compared to earlier VR systems. The study hypotheses include: * The integration of VR nature-based experiences with standard care will be feasible, acceptable, and will result in greater reductions in depressive symptoms compared to standard care or VR-only interventions. * The integration of VR nature-based experiences with standard care will result in greater reductions in stress and anxiety, better sleep, less insomnia, and improved fatigue compared to standard care alone or VR-only interventions.

Recruiting
Has No Placebo

University of Michigan

Hala Darwish, PhD

Apple Inc.

Have you considered Celexa clinical trials?

We made a collection of clinical trials featuring Celexa, we think they might fit your search criteria.
Go to Trials
Image of Medical University of South Carolina (MUSC), Brain Stimulation Laboratory Institute of Psychiatry in Charleston, United States.

Mindfulness Training for Depression

18 - 70
All Sexes
Charleston, SC

This NIH-funded single-arm pilot tests the feasibility, acceptability, and preliminary effects of embedding brief guided mindfulness practice (via the Healthy Minds smartphone app) into the inter-session intervals of clinically administered accelerated intermittent theta-burst stimulation (aiTBS) for major depressive disorder (MDD). Participants receive aiTBS as standard clinical care at MUSC; the research intervention is daily guided mindfulness practice during the aiTBS course. Outcomes include feasibility/acceptability, changes in state mindfulness and hedonic tone (Day 0 to Day 5), perceived ease of meditation, trait mindfulness at 4 and 12 weeks, and durability of antidepressant response (PHQ-9) at 4 and 12 weeks.

Waitlist Available
Has No Placebo

Medical University of South Carolina (MUSC), Brain Stimulation Laboratory Institute of Psychiatry

Clayton Olash, MD

Have you considered Celexa clinical trials?

We made a collection of clinical trials featuring Celexa, we think they might fit your search criteria.
Go to Trials
Image of University of South Florida in Tampa, United States.

Web-Based Program for Parenting Stress

18+
All Sexes
Tampa, FL

The goal of this clinical trial is to evaluate the feasibility, usability, and preliminary benefits of implementing ACT Together for parents of children with disabilities in pediatric outpatient clinics. ACT Together includes six self-paced, web-based modules and brief weekly one-on-one coaching sessions led by a trained occupational therapist. The program is based on acceptance and commitment therapy (ACT), which teaches practical skills to help people handle stress and difficult thoughts or feelings while taking steps toward what matters to them. The main questions this study aims to answer are: * Can parents and occupational therapists complete the study activities as planned (e.g., module completion, coaching sessions, and surveys)? * Is the program usable and acceptable/appropriate/feasible to implement in this setting? * Do parents show improvements in mental health and coping-related outcomes after participating in the program? * What are the experiences and perspectives of parents and therapists regarding the program? Parents as participants will: * Complete six self-paced web-based modules and brief weekly individual coaching sessions with a trained occupational therapist. * Complete online questionnaires before starting and after completing the program. * Take part in one online interview about their experiences and perspectives on the program. Occupational therapists as participants will: * Complete therapist training materials and deliver brief individual coaching sessions to parent participants, including completing a post-session checklist. * Complete brief online questionnaires before starting and after delivering the program. * Take part in one online interview about their experiences and perspectives on the program.

Waitlist Available
Has No Placebo

University of South Florida

Areum Han, PhD

Image of Worcester Recovery Center and Hospital in Worcester, United States.

Changing Lives and Changing Outcomes-9 for Serious Mental Illness

18+
All Sexes
Worcester, MA

People with serious mental illness (depression, bipolar, and schizophrenia spectrum disorders) have high rates of repeated criminal legal involvement and psychiatric hospitalizations. Longstanding research shows that in addition to treating clients' symptoms of mental illness, targeting risk factors for legal involvement can help reduce their chances of future incarcerations. Because hospitals are becoming increasingly forensic, treatment programs that address both mental illness and risk factors for legal involvement may be especially helpful in a state hospital setting, like Worcester Recovery Center and Hospital (WRCH). This treatment study offers an adjunctive 9-session intervention, Changing Lives and Changing Outcomes-9 (CLCO-9), for patients at WRCH; this program is designed to help people with serious mental illness who are involved in the legal system increase their awareness of their mental health and reduce their chances of future legal involvement. The investigators are proposing a treatment study testing the use of the CLCO-9 group intervention with patients with serious mental illness with current or previous criminal legal involvement at Worcester Recovery Center and Hospital (WRCH). The study has three aims: 1. Evaluate feasibility, fidelity, and patient satisfaction during the implementation of the CLCO-9 group treatment at WRCH 2. Evaluate CLCO-9's effectiveness on improving patient's self-reported mental health, and behavioral indicators of mental health and risk factors for legal involvement 3. Explore changes in WRCH clinicians' knowledge and attitudes about treating risk factors for criminal legal involvement. To test these aims, the research team will employ a two-phase study. In the first phase, the researchers will implement the intervention and make necessary adjustments to maximize the success of the implementation. In the second phase, the researchers will evaluate the treatment program's effectiveness in producing change from pre- to post-treatment. All patient participants in this study will receive the intervention. The projected sample size is about 20 treatment completers and 4 to 8 group leaders.

Waitlist Available
Has No Placebo

Worcester Recovery Center and Hospital

Faith Scanlon, PhD

Have you considered Celexa clinical trials?

We made a collection of clinical trials featuring Celexa, we think they might fit your search criteria.
Go to Trials